Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993067 ISBN 13: 9780309993067
Librería: Books From California, Simi Valley, CA, Estados Unidos de America
EUR 14,02
Cantidad disponible: 1 disponibles
Añadir al carritopaperback. Condición: Very Good.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993067 ISBN 13: 9780309993067
Librería: California Books, Miami, FL, Estados Unidos de America
EUR 29,78
Cantidad disponible: 5 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por National Academies Press, Washington, 2025
ISBN 10: 0309993067 ISBN 13: 9780309993067
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 33,13
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. This is the first of two reports requested by the Social Security Administration (SSA) to address best practices and community experiences in the management and treatment of sickle cell disease (SCD). SCD, a group of inherited blood disorders affecting approximately 100,000 people in the United States, is a chronic, life-long condition that affects every organ system in the body. The life of an individual with SCD is often complicated by frequent bouts of extreme pain and hospitalizations, fatigue, organ damage, and mental health conditions. The cumulative burden of SCD-related health effects can significantly affect quality of life, including the ability to regularly attend and participate fully in school and work.In response to SSA's request, the National Academies of Sciences, Engineering, and Medicine convened an expert, ad hoc committee to review the latest published scientific research and generate findings and conclusions on a variety of topics related to SCD. This report is the first report in a two-report series, and presents the committee's findings and conclusions pertaining to SCD pain crises, pain management, and treatment settings relevant to SSA disability determinations. This is the first of two reports requested by the Social Security Administration (SSA) to address best practices and community experiences in the management and treatment of sickle cell disease (SCD). Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Idioma: Inglés
Publicado por National Academies Press 3/12/2026, 2026
ISBN 10: 0309993067 ISBN 13: 9780309993067
Librería: BargainBookStores, Grand Rapids, MI, Estados Unidos de America
EUR 40,94
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback or Softback. Condición: New. Sickle Cell Disease in Social Security Disability Evaluations: Pain and Treatment Settings. Book.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993067 ISBN 13: 9780309993067
Librería: Revaluation Books, Exeter, Reino Unido
EUR 36,45
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. 144 pages. 5.99x0.40x8.91 inches. In Stock.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993067 ISBN 13: 9780309993067
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 38,59
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback / softback. Condición: New. New copy - Usually dispatched within 4 working days.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993067 ISBN 13: 9780309993067
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 57,93
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. 2025. paperback. . . . . . Books ship from the US and Ireland.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993067 ISBN 13: 9780309993067
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 66,65
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. 2025. paperback. . . . . .
Idioma: Inglés
Publicado por National Academies Press, Washington, 2025
ISBN 10: 0309993067 ISBN 13: 9780309993067
Librería: AussieBookSeller, Truganina, VIC, Australia
EUR 58,25
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. This is the first of two reports requested by the Social Security Administration (SSA) to address best practices and community experiences in the management and treatment of sickle cell disease (SCD). SCD, a group of inherited blood disorders affecting approximately 100,000 people in the United States, is a chronic, life-long condition that affects every organ system in the body. The life of an individual with SCD is often complicated by frequent bouts of extreme pain and hospitalizations, fatigue, organ damage, and mental health conditions. The cumulative burden of SCD-related health effects can significantly affect quality of life, including the ability to regularly attend and participate fully in school and work.In response to SSA's request, the National Academies of Sciences, Engineering, and Medicine convened an expert, ad hoc committee to review the latest published scientific research and generate findings and conclusions on a variety of topics related to SCD. This report is the first report in a two-report series, and presents the committee's findings and conclusions pertaining to SCD pain crises, pain management, and treatment settings relevant to SSA disability determinations. This is the first of two reports requested by the Social Security Administration (SSA) to address best practices and community experiences in the management and treatment of sickle cell disease (SCD). Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Idioma: Inglés
Publicado por National Academies Press Mär 2026, 2026
ISBN 10: 0309993067 ISBN 13: 9780309993067
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 38,46
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Neuware - This is the first of two reports requested by the Social Security Administration (SSA) to address best practices and community experiences in the management and treatment of sickle cell disease (SCD). SCD, a group of inherited blood disorders affecting approximately 100,000 people in the United States, is a chronic, life-long condition that affects every organ system in the body. The life of an individual with SCD is often complicated by frequent bouts of extreme pain and hospitalizations, fatigue, organ damage, and mental health conditions. The cumulative burden of SCD-related health effects can significantly affect quality of life, including the ability to regularly attend and participate fully in school and work. In response to SSA's request, the National Academies of Sciences, Engineering, and Medicine convened an expert, ad hoc committee to review the latest published scientific research and generate findings and conclusions on a variety of topics related to SCD. This report is the first report in a two-report series, and presents the committee's findings and conclusions pertaining to SCD pain crises, pain management, and treatment settings relevant to SSA disability determinations.